Ha Tay Pharmaceutical JSC (HNX:DHT)
67,600
-1,600 (-2.31%)
At close: Mar 9, 2026
Ha Tay Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,122,805 | 6,340,200 | 7,822,325 | 1,893,826 | 1,027,245 | 1,188,329 | Upgrade
|
| Market Cap Growth | -14.03% | -18.95% | 313.04% | 84.36% | -13.56% | 5.54% | Upgrade
|
| Enterprise Value | 6,250,061 | 6,536,629 | 8,001,132 | 2,176,376 | 1,106,314 | 1,060,741 | Upgrade
|
| Last Close Price | 67600.00 | 70000.00 | 86363.64 | 20336.49 | 12284.00 | 13536.16 | Upgrade
|
| PE Ratio | 114.11 | 118.16 | 108.99 | 22.27 | 10.79 | 17.49 | Upgrade
|
| PS Ratio | 2.55 | 2.64 | 3.75 | 0.95 | 0.56 | 0.74 | Upgrade
|
| PB Ratio | 5.51 | 5.71 | 7.40 | 1.78 | 1.29 | 1.58 | Upgrade
|
| P/TBV Ratio | 5.66 | 5.86 | 7.61 | 1.83 | 1.33 | 1.63 | Upgrade
|
| P/FCF Ratio | 34.60 | 35.83 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 27.13 | 28.09 | 279.78 | 6.99 | - | - | Upgrade
|
| EV/Sales Ratio | 2.60 | 2.72 | 3.84 | 1.09 | 0.60 | 0.66 | Upgrade
|
| EV/EBITDA Ratio | 86.51 | 100.79 | 82.49 | 18.71 | 9.23 | 13.51 | Upgrade
|
| EV/EBIT Ratio | 129.94 | 160.56 | 104.57 | 21.94 | 10.80 | 17.09 | Upgrade
|
| EV/FCF Ratio | 35.32 | 36.94 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.30 | 0.45 | 0.47 | 0.42 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 5.14 | 5.14 | 4.85 | 4.33 | 2.81 | 3.69 | Upgrade
|
| Debt / FCF Ratio | 1.88 | 1.88 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.09 | 0.09 | 0.27 | 0.11 | 0.24 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.52 | 1.52 | 2.99 | 1.05 | 1.59 | -1.69 | Upgrade
|
| Net Debt / FCF Ratio | 0.56 | 0.56 | -2.52 | -1.27 | -0.67 | 1.59 | Upgrade
|
| Asset Turnover | 1.25 | 1.25 | 1.11 | 1.21 | 1.36 | 1.49 | Upgrade
|
| Inventory Turnover | 4.23 | 4.23 | 4.12 | 4.28 | 4.12 | 4.08 | Upgrade
|
| Quick Ratio | 0.47 | 0.47 | 0.41 | 0.81 | 0.47 | 1.15 | Upgrade
|
| Current Ratio | 1.22 | 1.22 | 1.21 | 1.69 | 1.80 | 2.10 | Upgrade
|
| Return on Equity (ROE) | 5.45% | 5.45% | 7.08% | 9.54% | 12.75% | 12.95% | Upgrade
|
| Return on Assets (ROA) | 1.32% | 1.32% | 2.54% | 3.75% | 4.73% | 3.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.64% | 2.56% | 4.76% | 7.34% | 10.22% | 9.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.40% | 3.40% | 6.60% | 8.00% | 11.30% | 8.20% | Upgrade
|
| Earnings Yield | 0.88% | 0.85% | 0.92% | 4.49% | 9.27% | 5.72% | Upgrade
|
| FCF Yield | 2.89% | 2.79% | -1.47% | -5.05% | -27.84% | -7.05% | Upgrade
|
| Dividend Yield | 1.31% | - | - | - | - | 2.40% | Upgrade
|
| Payout Ratio | - | - | 111.73% | - | 53.87% | 29.96% | Upgrade
|
| Buyback Yield / Dilution | - | 0.00% | -62.83% | - | - | 0.77% | Upgrade
|
| Total Shareholder Return | 1.31% | - | -62.83% | - | - | 3.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.